Search research articles
Contact Us
Filters
Showing results (271-280 of 383) with videos related to
Page
of 39
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2002
The association of p21((WAF-1/CIP1)) with progression to androgen-independent prostate cancer
Karim Fizazi, Luis A Martinez, Charles R Sikes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2008
Soluble ErbB3 levels in bone marrow and plasma of men with prostate cancer
Sue-Hwa Lin, Yu-Chen Lee, Michel B Choueiri, et al.
British Journal of Cancer
|
June 27, 2002
Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours
K Fizazi, D M Prow, K-A Do, et al.
Cancer
|
August 27, 2014
Randomized phase 2 study of bone-targeted therapy containing strontium-89 in advanced castrate-sensitive prostate cancer
Mehmet Asim Bilen, Marcella M Johnson, Paul Mathew, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2011
A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma
A J Zurita, E Jonasch, X Wang, et al.
Cancer Research Communications
|
November 6, 2023
Monitoring Glucocorticoid Receptor in Plasma-derived Extracellular Vesicles as a Marker of Resistance to Androgen Receptor Signaling Inhibition in Prostate Cancer
Emanuela Gentile, Andrew W Hahn, Jian H Song, et al.
Cancer Chemotherapy and Pharmacology
|
July 22, 2017
Clinical predictors of survival in patients with castration-resistant prostate cancer receiving sipuleucel-T cellular immunotherapy
Mehmet Asim Bilen, Kenneth R Hess, Sumit K Subudhi, et al.
Cancer Research
|
May 21, 2010
Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts
Chih-Fen Huang, Cristina Lira, Khoi Chu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 9, 2011
Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: a phase 1/2 clinical trial
A J Zurita, D J George, N D Shore, et al.
Molecular Cancer Research : MCR
|
September 16, 2022
Subtype and Site Specific-Induced Metabolic Vulnerabilities in Prostate Cancer
Federica Mossa, Daniele Robesti, Ramachandran Sumankalai, et al.
Page
of 39
Search research articles
Search
Showing results (271-280 of 383) with videos related to
Sort By:
Page
of 39
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2002
The association of p21((WAF-1/CIP1)) with progression to androgen-independent prostate cancer
Karim Fizazi, Luis A Martinez, Charles R Sikes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2008
Soluble ErbB3 levels in bone marrow and plasma of men with prostate cancer
Sue-Hwa Lin, Yu-Chen Lee, Michel B Choueiri, et al.
British Journal of Cancer
|
June 27, 2002
Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours
K Fizazi, D M Prow, K-A Do, et al.
Cancer
|
August 27, 2014
Randomized phase 2 study of bone-targeted therapy containing strontium-89 in advanced castrate-sensitive prostate cancer
Mehmet Asim Bilen, Marcella M Johnson, Paul Mathew, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2011
A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma
A J Zurita, E Jonasch, X Wang, et al.
Cancer Research Communications
|
November 6, 2023
Monitoring Glucocorticoid Receptor in Plasma-derived Extracellular Vesicles as a Marker of Resistance to Androgen Receptor Signaling Inhibition in Prostate Cancer
Emanuela Gentile, Andrew W Hahn, Jian H Song, et al.
Cancer Chemotherapy and Pharmacology
|
July 22, 2017
Clinical predictors of survival in patients with castration-resistant prostate cancer receiving sipuleucel-T cellular immunotherapy
Mehmet Asim Bilen, Kenneth R Hess, Sumit K Subudhi, et al.
Cancer Research
|
May 21, 2010
Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts
Chih-Fen Huang, Cristina Lira, Khoi Chu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 9, 2011
Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: a phase 1/2 clinical trial
A J Zurita, D J George, N D Shore, et al.
Molecular Cancer Research : MCR
|
September 16, 2022
Subtype and Site Specific-Induced Metabolic Vulnerabilities in Prostate Cancer
Federica Mossa, Daniele Robesti, Ramachandran Sumankalai, et al.
Page
of 39